Notice of Change: Extension of PA-18-705 "SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)"
Notice Number:
NOT-NS-21-042

Key Dates

Release Date:

March 16, 2021

Related Announcements

PA-18-705 - SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

This notice informs applicants of an extension to PA-18-705, "SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)". This Funding Opportunity Announcement (FOA) has been extended by one additional council round to expire on September 6, 2021.

Due to the extension, the following dates have been added:

New, Renewal, Resubmission, and Revision Application Due Date: September 5, 2021.

The following section of PA-18-705 "SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)" has been modified, as indicated below.

Currently Reads:

Part 1. Overview

Key Dates

Application Due Date(s)  

Standard dates apply, by 5:00 PM local time of applicant organization.

*** Note new SBIR/STTR Standard Due Dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review Standard dates apply
Advisory Council Review Standard dates apply
Earliest Start Date Standard dates apply
Expiration Date April 6, 2021


Modified to Read (changes shown in bold italics):

Part 1. Overview

Key Dates:

Application Due Date(s)  

Standard dates apply, by 5:00 PM local time of applicant organization.

*** Note new SBIR/STTR Standard Due Dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review Standard dates apply
Advisory Council Review Standard dates apply
Earliest Start Date Standard dates apply
Expiration Date September 6, 2021


All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices